BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiore-Gartland A, Carpp LN, Naidoo K, Thompson E, Zak DE, Self S, Churchyard G, Walzl G, Penn-Nicholson A, Scriba TJ, Hatherill M. Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention. Tuberculosis (Edinb) 2018;109:61-8. [PMID: 29559122 DOI: 10.1016/j.tube.2017.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Sinigaglia A, Peta E, Riccetti S, Venkateswaran S, Manganelli R, Barzon L. Tuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers. Cells 2020;9:E2160. [PMID: 32987746 DOI: 10.3390/cells9102160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, Ma S, Meermeier E, Lewinsohn DM, Sherman DR. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev 2018;31:e00021-18. [PMID: 30021818 DOI: 10.1128/CMR.00021-18] [Cited by in Crossref: 132] [Cited by in F6Publishing: 77] [Article Influence: 33.0] [Reference Citation Analysis]
3 Lalvani A, Berrocal-Almanza LC, Halliday A. Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination. PLoS Med 2019;16:e1002814. [PMID: 31125334 DOI: 10.1371/journal.pmed.1002814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Mendelsohn SC, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Mbandi SK, Borate B, Hadley K, Hikuam C, Musvosvi M, Bilek N, Erasmus M, Jaxa L, Raphela R, Nombida O, Kaskar M, Sumner T, White RG, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Tameris M, Walzl G, Naidoo K, Churchyard G, Scriba TJ, Hatherill M; CORTIS-HR Study Team. Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study. Lancet Glob Health 2021;9:e841-53. [PMID: 33862012 DOI: 10.1016/S2214-109X(21)00045-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Russell DG. Tuberculosis Progression Does Not Necessarily Equate with a Failure of Immune Control. Microorganisms 2019;7:E185. [PMID: 31252553 DOI: 10.3390/microorganisms7070185] [Reference Citation Analysis]
6 Suliman S, Thompson EG, Sutherland J, Weiner J 3rd, Ota MOC, Shankar S, Penn-Nicholson A, Thiel B, Erasmus M, Maertzdorf J, Duffy FJ, Hill PC, Hughes EJ, Stanley K, Downing K, Fisher ML, Valvo J, Parida SK, van der Spuy G, Tromp G, Adetifa IMO, Donkor S, Howe R, Mayanja-Kizza H, Boom WH, Dockrell HM, Ottenhoff THM, Hatherill M, Aderem A, Hanekom WA, Scriba TJ, Kaufmann SHE, Zak DE, Walzl G; GC6-74 cohort study team, The ACS cohort study team. Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis. Am J Respir Crit Care Med 2018;197:1198-208. [PMID: 29624071 DOI: 10.1164/rccm.201711-2340OC] [Cited by in Crossref: 113] [Cited by in F6Publishing: 70] [Article Influence: 28.3] [Reference Citation Analysis]
7 Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Kimbung Mbandi S, Borate B, Mendelsohn SC, Hadley K, Hikuam C, Kaskar M, Musvosvi M, Bilek N, Self S, Sumner T, White RG, Erasmus M, Jaxa L, Raphela R, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Tameris M, Walzl G, Naidoo K, Churchyard G, Hatherill M; CORTIS-01 Study Team. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial. Lancet Infect Dis 2021;21:354-65. [PMID: 33508224 DOI: 10.1016/S1473-3099(20)30914-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
8 Lee A, Xie YL, Barry CE, Chen RY. Current and future treatments for tuberculosis. BMJ 2020;368:m216. [PMID: 32122882 DOI: 10.1136/bmj.m216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Kumar NP, Hissar S, Thiruvengadam K, Banurekha VV, Suresh N, Shankar J, S E, N S G, S K, J G, M A A, Baskaran D, Tripathy S, Swaminathan S, Babu S. Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis. Front Immunol 2021;12:653898. [PMID: 33936077 DOI: 10.3389/fimmu.2021.653898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Atmakuri K, Penn-Nicholson A, Tanner R, Dockrell HM. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India. Tuberculosis (Edinb) 2018;113:55-64. [PMID: 30514514 DOI: 10.1016/j.tube.2018.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Mendelsohn SC, Mbandi SK, Fiore-gartland A, Penn-nicholson A, Musvosvi M, Mulenga H, Fisher M, Hadley K, Erasmus M, Nombida O, Tameris M, Walzl G, Naidoo K, Churchyard G, Hatherill M, Scriba TJ. Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR. Commun Med 2022;2. [DOI: 10.1038/s43856-022-00086-8] [Reference Citation Analysis]
12 Emery JC, Richards AS, Dale KD, McQuaid CF, White RG, Denholm JT, Houben RMGJ. Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease. Proc Biol Sci 2021;288:20201635. [PMID: 33467995 DOI: 10.1098/rspb.2020.1635] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Kik SV, Schumacher S, Cirillo DM, Churchyard G, Boehme C, Goletti D, Rangaka MX, Denkinger CM, Lienhardt C, Gilpin C, Matteelli A, Cobelens F. An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. Eur Respir J 2018;52:1800946. [PMID: 30139776 DOI: 10.1183/13993003.00946-2018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
14 Kontsevaya I, Lange C, Comella-Del-Barrio P, Coarfa C, DiNardo AR, Gillespie SH, Hauptmann M, Leschczyk C, Mandalakas AM, Martinecz A, Merker M, Niemann S, Reimann M, Rzhepishevska O, Schaible UE, Scheu KM, Schurr E, Abel Zur Wiesch P, Heyckendorf J. Perspectives for systems biology in the management of tuberculosis. Eur Respir Rev 2021;30:200377. [PMID: 34039674 DOI: 10.1183/16000617.0377-2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Perumal P, Abdullatif MB, Garlant HN, Honeyborne I, Lipman M, McHugh TD, Southern J, Breen R, Santis G, Ellappan K, Kumar SV, Belgode H, Abubakar I, Sinha S, Vasan SS, Joseph N, Kempsell KE. Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR. Front Immunol 2020;11:612564. [PMID: 33841389 DOI: 10.3389/fimmu.2020.612564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]